AnaptysBio, Inc.
ANABBiotechnology
$48.64−3.68%As of Oct 29vs prior close
- Market cap
- $1.5B
- P/E (TTM)
- –
- P/E (FY1)
- 11.7×
- From 52W high
- −30.33%
- EPS (LTM)
- -$1.02
- Revenue (LTM)
- $232.4M
- Net margin
- -11.53%
- Dividend yield
- 0.00%
Nomior Score
66
Steady ProfileSpeculativeTop 14% of the scored universe
Growth—
Quality67
Value59
Momentum82
Resilience44
Growth
+34.14%revenue a year over 9 fiscal years
YE16 $16.7MLTM $232.4M
Connections
Revenue to profitQ1 YE26
The operating loss was 136% of revenue, wider by 36 pts on a year.
Who owns it
2funds